Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update. | Eur J Hum Genet | 2022 | 34983940 | PubTator, text mining | PubMed |
| Deciphering the Core Metabolites of Fanconi Anemia by Using a Multi-Omics Composite Network. | J Microbiol Biotechnol | 2022 | 34954697 | PubTator, text mining | PubMed |
| Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. | Eur Urol | 2022 | 34953602 | PubTator, text mining | PubMed |
| Risk of cancer in heterozygous relatives of patients with Fanconi anemia. | Genet Med | 2022 | 34906449 | PubTator, text mining | PubMed |
| Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis. | Transl Oncol | 2022 | 34902740 | PubTator, text mining | PubMed |
| Descriptive Longitudinal Analysis of Stereotypy and Corresponding Changes in Psychotropic Medication. | Dev Neurorehabil | 2022 | 34865596 | PubTator, text mining | PubMed |
| In silico study of missense variants of FANCA, FANCC and FANCG genes reveals high risk deleterious alleles predisposing to Fanconi anemia pathogenesis. | Gene | 2022 | 34864095 | PubTator, text mining | PubMed |
| Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept. | Clin Exp Dent Res | 2022 | 34854575 | PubTator, text mining | PubMed |
| LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells. | Blood Adv | 2022 | 34844262 | PubTator, text mining | PubMed |
| Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations. | Blood Adv | 2022 | 34807970 | PubTator, text mining | PubMed |
Exposure assessment of nanotitanium oxide powder handling using real-time size-selective particle number concentration measurements and X-ray fluorescence spectrometry -The possibility of exposure to nonagglomerated nanomaterials during the handling of nanomaterial fine powders. | Ind Health | 2022 | 34803120 | PubTator, text mining | PubMed |
| Translational research for bone marrow failure patients. | Exp Hematol | 2022 | 34801643 | PubTator, text mining | PubMed |
| Genetics of ovarian insufficiency and defects of folliculogenesis. | Best Pract Res Clin Endocrinol Metab | 2022 | 34794894 | PubTator, text mining | PubMed |
| Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. | Cancer Med | 2022 | 34791836 | PubTator, text mining | PubMed |
| A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy. | Transfusion | 2022 | 34751952 | PubTator, text mining | PubMed |
| Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies. | Front Med | 2022 | 34741701 | PubTator, text mining | PubMed |
| Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score. | Clin Cancer Res | 2022 | 34740923 | PubTator, text mining | PubMed |
| Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers. | Mol Cancer Ther | 2022 | 34725190 | PubTator, text mining | PubMed |
| Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies. | J Clin Immunol | 2022 | 34716846 | PubTator, text mining | PubMed |
| Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. | Eur Urol | 2022 | 34711450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=55